Leadership in Medical Technology

Led P&L operations for EMEA Heating Controls business unit, managing brands like Drayton and Eberle at Invensys.

Managed global residential control operations, focusing on North American market, at Invensys.

Oversaw 7 global industrial technology businesses (e.g., Red Lion Controls, Omega Engineering) at Spectris, providing strategic direction and operational improvements across two major business segments.

Oversaw global commercial operations for Bosch's lawn and garden business unit, focusing on optimization and market expansion.

Collaborated with Power Tools executive committee on strategic projects related to market positioning and portfolio development at Bosch.

Contributed to a lean operations strategy for a UK retailer while working as a summer associate at McKinsey.

Worked in various roles, leading strategic change and restructuring initiatives in international settings.

Facilitated personal and leadership development programs for individuals and groups.

Started career with practical experience on electronics engineering projects.

Simon earned a Bachelor of Arts (BA) in Natural Sciences with First-Class Honours from Fitzwilliam College, University of Cambridge.

Dr. Chris Martin possesses deep experience in biopharmaceuticals and technology, including co-founding and leading companies like Spirogen and ADC Therapeutics.

Currently holds positions as Chairman of Tokamak Energy, Tagworks Pharmaceuticals, and Myricx Bio.

Experience and proficiency in managing investments, guiding startups in life sciences, biotechnology, and digital health.

Proven ability to teach and develop business courses for higher education focusing on venture capital and innovation.

Published works and research in plant molecular biology and venture capital strategies.

Strong leadership in venture capital portfolios, technology identification, and growth of portfolio companies.

Proven ability to lead complex organizations, drive profitability, and manage strategic transformations.

Significant board-level experience in remuneration, compliance, and corporate governance.

Comprehensive knowledge of industrial controls, instrumentation, and HVAC systems.

Demonstrated ability to lead strategic change and restructuring across multinational companies.

Successfully managed global product portfolios, led growth initiatives, and expanded market reach.

Expertise in enhancing productivity through lean strategies and optimizing P&L.

Leading investment efforts in food sciences, industrial biotechnology, and digital health.

Expertise in fostering innovation in businesses.

Managing investments in a portfolio.

Scientific research on plants and their genetic mechanisms.

The head of a business that invests in and supports startups.

Deep experience in biopharmaceuticals and technology, including launching and leading companies like Spirogen and ADC Therapeutics.

World leader in fusion energy using spherical tokamak technology and HTS magnets.

Pioneering precision therapies, focusing on ADCs for cancer treatment.

Develops novel payloads for ADCs targeting cancer, using NMT inhibitors.

Biopharmaceutical company using oligoDOM® nanoparticles to enhance vaccines and target infectious diseases.

Global leader in ADCs, developing therapies for hematologic malignancies and solid tumors.

Combination of antibodies and drugs to target cancer cells.

Magnets used in fusion energy production that operate at high temperatures.

Highest leadership position in a company's board of directors.

Managed projects in industrial inkjet technologies, focusing on system design for high-precision applications.

Designed mechanical systems for industrial and infrastructure applications.

Summer research on materials for aviation technologies.

Gained experience in water infrastructure and materials engineering.

Expertise in advanced cryogenic systems for biopharmaceutical applications.

Proven ability to lead research teams and drive innovation in biotechnology.

Strong background in mechanical design, material science, and system engineering.

Skilled in managing complex engineering projects, from concept to execution.

Specialized in developing bioprocessing technologies for cellular therapies and gene therapy applications.

Chris Martin has a long history in biotechnology, technology and business leadership, demonstrated through his roles as co-founder and CEO at Spirogen, chairman at Crescent Diagnostics, and chairman of the governors at Sciona.

Spirogen, a biotechnology company co-founded by Chris Martin, was acquired by AstraZeneca's MedImmune for $440 million.

A company focused on osteoporosis diagnostics using Raman Spectroscopy, chaired by Chris Martin.

A gene-based health and nutrition analysis company, co-founded and led by Chris Martin, offering personalized recommendations.

Chris Martin served as Chairman of the Governors at Ryde School, overseeing strategic planning and governance.

A UK-listed fund focusing on investments in technology companies where Chris Martin was a Non-Executive Director.

An early-stage investment fund backed by public bodies, where Chris Martin was a Non-Executive Director.

Chris Martin received an MBA specializing in Management of Technology and Innovation from IMD Business School.